doi: 10.15585/mmwr.mm6532a5.
Announcement: Clinical Practice Guidelines Published for Treatment of Drug-Susceptible Tuberculosis
- PMID: 27537009
- DOI: 10.15585/mmwr.mm6532a5
Item in Clipboard
Announcement: Clinical Practice Guidelines Published for Treatment of Drug-Susceptible Tuberculosis
MMWR Morb Mortal Wkly Rep.
.
Free article
Abstract
The American Thoracic Society, CDC, and the Infectious Diseases Society of America (IDSA) have jointly sponsored the development of guidelines for the treatment of drug-susceptible tuberculosis, which were published by IDSA in Clinical Infectious Diseases on August 11, 2016 (1) and are available through IDSA (http://www.idsociety.org/Index.aspx) and CDC (http://www.cdc.gov/tb/publications/guidelines/treatment.htm).
Similar articles
-
New Guidelines for the Treatment of Drug-Susceptible Tuberculosis from the American Thoracic Society, Centers for Disease Control and Prevention, and the Infectious Diseases Society of America. Now Comes the Hard Part.Am J Respir Crit Care Med. 2016 Oct 1;194(7):791-793. doi: 10.1164/rccm.201607-1419ED. Am J Respir Crit Care Med. 2016. PMID: 27556737 No abstract available.
-
The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis.Eur Respir J. 2016 Oct;48(4):963-971. doi: 10.1183/13993003.01356-2016. Epub 2016 Sep 1. Eur Respir J. 2016. PMID: 27587550 No abstract available.
-
Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.MMWR Recomm Rep. 2005 Nov 4;54(RR-12):1-81. MMWR Recomm Rep. 2005. PMID: 16267499
-
Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 2):S221-47. doi: 10.1164/ajrccm.161.supplement_3.ats600. Am J Respir Crit Care Med. 2000. PMID: 10764341 Review. No abstract available.
-
Tuberculosis: an overview.Prim Care. 2013 Sep;40(3):743-56. doi: 10.1016/j.pop.2013.06.003. Prim Care. 2013. PMID: 23958367 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
